CCAP Company Profile and Key Details

Crescent Capital BDC, Inc. (NASDAQ:CCAP) closed at $14.61 USD, losing -$0.04 (-0.27%) from the previous close of $14.65. The stock is currently mid-range between its 52-week high and low $13.03 and $20.19. With a market capitalization of about $541.47 million, Crescent Capital BDC, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.58). Key stats such as the average daily volume over the past year has been around 240.33 thousand shares, in line with its 52-week average. Headquartered in Los Angeles, CA, Crescent Capital BDC, Inc. operates in the Financial Services sector and the Asset Management industry. Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund.

Crescent Capital BDC, Inc. generated EPS of $0.97 over the past year. Five-year average earnings growth is 3.29%. Wall Street analysts project EPS growth of -14.99% annually over the next five years. The latest quarter delivered EPS of $0.46. The next quarter is forecast at $0.44. Next year's EPS is expected at -$0.55. Analyst sentiment is neutral. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $19.00 to $14.00. The high target offers 29.69% upside. The low target suggests -4.44% downside. The mean target is $17.21. This offers 17.47% upside. Crescent Capital BDC, Inc. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -1.06%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 1.03% in August 12, 2024.

Crescent Capital BDC, Inc. last paid a dividend of 1.73 per share, this equals a trailing yield of roughly 11.95%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $41.06. This means the shares are trading below this model’s fair value.

CCAP has shown weak momentum, losing -1.68% over the past week and -6.87% over the past quarter, though year-to-date performance is down -23.78%. Short-term trend indicators are mixed aligned (SMA20 0.41%, SMA50 3.15%, SMA200 -2.49%). The stock’s 14-day RSI is 52.99 (neutral), while the ATR of 0.3 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -26.77% below its high and over 12.43% above its low. Average 10-day trading volume of 336.79 thousand shares is significantly above the 3-month average of 211.73 thousand, indicating heightened recent market interest.

Crescent Capital BDC, Inc. (NASDAQ:CCAP) shares are down -23.78% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Crescent Capital BDC, Inc. trading at a premium to the broader market with a P/E of 12.29. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $18.10, suggesting 23.55% upside. Our AI forecast model points to short-term strength (0.68% over two weeks), a medium-term fall (-3.75% over three months), and a longer-term gain (48.6% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Crescent Capital BDC, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.68%, with price expected at $14.75 by January 02, 2026, within a range of $14.48 to $15.02 3-Month Outlook: Projected fall of -3.75%, reaching $14.10 by March 19, 2026, with a range of $13.21 to $14.88. 1-Year Outlook: Projected gain of 48.6%, with price at $21.77 by December 18, 2026, within a range of $9.05 to $28.61.

Crescent Capital BDC, Inc. trades at a P/E ratio of 12.29, slightly below the S&P 500 average, with a price-to-sales ratio of 2.98 and a price-to-book ratio of 0.75 suggesting the stock is closer to book value. The P/FCF stands at 8.31, also above market averages.